Canaccord Genuity 40th Annual Growth Conference
Canaccord Genuity 40th Annual Growth Conference
August 13, 2020 at 8:00 A.M EDT
Rgenix is a privately-held clinical-stage biopharmaceutical company developing first-in-class drugs that target key pathways in cancer progression.
